Experimental study on treating hyperlipidemic fatty liver with Taizhi'an capsule / 中国中药杂志
China Journal of Chinese Materia Medica
; (24): 616-619, 2007.
Article
em Zh
| WPRIM
| ID: wpr-283420
Biblioteca responsável:
WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To observe the effects of Taizhi'an capsule in treatment of hyperlipidemic fatty liver.</p><p><b>METHOD</b>The model rats were induced by feeding high caloric diet for 8 weeks, then fifty rats were randomly divided into five groups, and each group had ten rats, the Taizhi'an groups (high dose 1 000 mg x kg(-1), middle dose 500 mg x kg(-1), low dose 250 mg x kg(-1)), the Yishanfu group and the model group. Liver index (liver weight/body weight), liver function, blood lipid, liver lipid, the content of MDA and SOD in liver were assayed after therapy, and observe Pathologic changes in rats liver.</p><p><b>RESULT</b>Liver index, blood lipid, liver lipid, liver function increased significantly (P < 0.001) in model rats, and the content of SOD in liver decreased significantly (P < 0.05), Liver histology expressed mild to moderate fat denaturation; After being treated with high and middle dose of Taizhi'an capsule for six weeks, blood lipid, liver function decreased significantly (P < 0.001), and liver lipid decreased significantly (P < 0.001, P <0.05), the content of SOD in liver increased significantly (P < 0.05), meanwhile liver histology was closed to normal.</p><p><b>CONCLUSION</b>Taizhian capsule is effective in the treatment of hyperlipidemic induced fatty liver.</p>
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Patologia
/
Farmacologia
/
Plantas Medicinais
/
Aspartato Aminotransferases
/
Superóxido Dismutase
/
Triglicerídeos
/
Triterpenos
/
Sangue
/
Cápsulas
/
Medicamentos de Ervas Chinesas
Limite:
Animals
Idioma:
Zh
Revista:
China Journal of Chinese Materia Medica
Ano de publicação:
2007
Tipo de documento:
Article